1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Combination Products

Combination Products

1 - 15 of 23 Results
Sort Results:
Chart: Comparison of Insulins (Canada) January 2025
Chart: Comparison of Insulins (United States)
 January 2025
Chart: Drugs for Type 2 Diabetes December 2024
Chart: Comparison of GLP-1 and GIP/GLP-1 Receptor Agonists
 August 2024
Technician Tutorial: Dispensing Insulin and Other Injectable Diabetes Meds August 2022
Chart: Stepwise Treatment of Type 2 Diabetes (Canada) June 2018
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
Article: Adlyxin and Soliqua Join a Crowded Market of Injectable Diabetes Meds January 2017
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
Article: Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes August 2013
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
Article: You'll hear claims that gliptins (Januvia, etc) decrease cardiovascular risk in diabetes patients November 2011
Article: The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes December 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes December 2008
Commentary: Updated Treatment Recommendations for Type 2 Diabetes December 2008